NSEGeneral Updates2d ago · 29 Oct 2026, 03:10 pm
General Updates
Laurus Labs Limited · LAURUSLABS
✦ AI SummaryMgmt Change
Laurus Labs Limited has informed the Exchange about the appointment of Mr. Kundan Kumar Jha as Joint Company Secretary of the Company, effective from November 1, 2026.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Laurus Labs Limited has informed the Exchange about appointment of Mr. Kundan Kumar Jha as Joint Company Secretary of the Company w.e.f. November 1, 2026
Attachments (1)
📄pdf
Download →
LAURUSLABS_29102026151022_JointCS29102026.pdf
View document text
October 29, 2026
To To
The Corporate Relations Department The Listing Department
BSE Limited National Stock Exchange of India Ltd.,
Phiroze Jeejeebhoy Towers, Exchange Plaza,
Dalal Street, Bandra Kurla Complex, Bandra (E),
Mumbai – 400 001 Mumbai – 400 051
Code: 540222 Code: LAURUSLABS
Dear Sir / Madam,
Sub: Approval for the appointment of Mr. Kundan Kumar Jha as Joint Company Secretary
Pursuant to the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015 (“SEBI Listing Regulations”), we would like to inform that the Board of Directors of the Company at
their meeting held on October 29, 2026, has inter alia based on the recommendation of the Nomination and
Remuneration Committee and in line with the Company’s succession planning process, approved the
appointment of Mr. Kundan Kumar Jha (Associate Member of the Institute of Company Secretaries of India
holding Membership No. A17612), as Joint Company Secretary, being a Key Managerial Personnel of the
Company, with effect from November 1, 2026.
The relevant details as required under the SEBI Listing Regulations read with SEBI Master Circular No.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, including a brief profile of Mr.
Kundan Kumar Jha is annexed herewith as Annexure.
The Board Meeting commenced at 02.00 p.m. (IST) and concluded at 02.47 p.m. (IST).
This is for your information and records.
Thanking you.
Yours sincerely,
For Laurus Labs Limited
V V Ravi Kumar
Executive Director and CFO
DIN: 01424180
Encl: A/a
Annexure
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015
(Pursuant to SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026)
Approval for the appointment of Mr. Kundan Kumar Jha, as Joint Company Secretary
a Reason for change viz. appointment, Appointment of Mr. Kundan Kumar Jha (Associate Member
re-appointment, resignation, of the Institute of Company Secretaries of India holding
removal, death or otherwise Membership No. A17612), as Joint Company Secretary,
being a Key Managerial Personnel of the Company, in line
with Company’s succession planning process.
b Date of appointment/ re- Appointment shall be effective from November 1, 2026
appointment/ cessation (as
applicable) & term of appointment/
re-appointment
c Brief profile (in case of Mr. Kundan is a qualified Company Secretary and a member
appointment) of the Institute of Company Secretaries of India (ICSI). He
brings over 23 years of extensive experience in corporate
governance, board processes, regulatory compliance,
corporate law, listing regulations, and legal affairs. Before
joining Laurus, he was associated with Cohance Lifesciences
Limited as Company Secretary and Head of Legal. Earlier in
his career, he held key positions at Dr. Reddy’s Laboratories
Limited, Rupa & Company Limited, Balrampur Chini Mills
Limited, and Keventer Group.
Throughout his professional journey, he has led numerous
strategic projects, governance initiatives, and
transformational changes across corporate secretarial,
regulatory compliance, and legal functions, including board
processes, mergers & acquisitions, under the Corporate Laws
and the Listing Regulations of SEBI and SEC.
d Disclosure of relationships between Not applicable
directors (in case of appointment of
a director).